Skip to main content
Clinical Trials/CTRI/2017/05/008517
CTRI/2017/05/008517
Not Yet Recruiting
Phase 3

Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on developmental Outcome Study - TORPIDO2

The University of Sydney represented by and acting through the NHMRC Clinical Trials Centre0 sites1,200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Sydney represented by and acting through the NHMRC Clinical Trials Centre
Enrollment
1200
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
The University of Sydney represented by and acting through the NHMRC Clinical Trials Centre

Eligibility Criteria

Inclusion Criteria

  • 1\)Premature infants from 23\+0 weeks to 28\+6 weeks Gestational Age.
  • 2\)Signed written informed consent by parents(s) or legal guardian(s)

Exclusion Criteria

  • 1\)Any known major cardio pulmonary abnormalities that could affect oxygenation or co\-genital malformitions that could affect neurodevelopmental outcomes.
  • 2\) Anticipated inability to follow up for two years, e.g. Parents normally resident overseas in an inaccessible location.

Outcomes

Primary Outcomes

Not specified

Similar Trials